Analgesics
Antiandrogens
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lactoferrin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Peg.. Lambda
Quercetin
Remdesivir
Vitamins

Other
Feedback
Home
Top
Results
Abstract
All zinc studies
Meta analysis
 
Feedback
Home
c19early.org COVID-19 treatment researchZincZinc (more..)
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta
Cannabidiol Meta Molnupiravir Meta
Colchicine Meta
Conv. Plasma Meta
Curcumin Meta Nigella Sativa Meta
Ensovibep Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Peg.. Lambda Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Ivermectin Meta
Lactoferrin Meta

All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Mortality 71% Improvement Relative Risk Death/hospitalization 27% Hospitalization 18% Zinc for COVID-19  Wu et al.  Sufficiency Are zinc levels associated with COVID-19 outcomes? Retrospective 2,894 patients in multiple countries (Jan 2022 - Apr 2023) Lower mortality (p=0.0048) and death/hosp. (p=0.03) c19early.org Wu et al., J. Infection, June 2023 Favors zinc Favors control

The association between zinc deficiency, and clinical outcomes of COVID-19

Wu et al., Journal of Infection, doi:10.1016/j.jinf.2023.06.021
Jun 2023  
  Twitter
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
TriNetX PSM retrospective 10,935 COVID-19 patients, showing higher mortality with zinc deficiency.
risk of death, 70.8% lower, HR 0.29, p = 0.005, high zinc levels (≥70µg/dL) 10 of 1,447 (0.7%), low zinc levels (<70µg/dL) 20 of 1,447 (1.4%), inverted to make HR<1 favor high zinc levels (≥70µg/dL), Kaplan–Meier.
risk of death/hospitalization, 27.3% lower, HR 0.73, p = 0.03, high zinc levels (≥70µg/dL) 81 of 1,447 (5.6%), low zinc levels (<70µg/dL) 107 of 1,447 (7.4%), NNT 56, inverted to make HR<1 favor high zinc levels (≥70µg/dL), Kaplan–Meier.
risk of hospitalization, 17.9% lower, HR 0.82, p = 0.21, high zinc levels (≥70µg/dL) 74 of 1,447 (5.1%), low zinc levels (<70µg/dL) 87 of 1,447 (6.0%), NNT 111, inverted to make HR<1 favor high zinc levels (≥70µg/dL), Kaplan–Meier.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Wu et al., 29 Jun 2023, retrospective, multiple countries, peer-reviewed, 9 authors, study period 1 January, 2022 - 30 April, 2023.
Contact: m880419@mail.chimei.org.tw, nicolar930@gmail.com, rositatsai@gmail.com, andy10271@gmail.com, liu.tingkle@gmail.com, b0807246@gmail.com, 60028a@gmail.com, wayne54019@gmail.com, dtmed141@gmail.com.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperZincAll
The association between zinc deficiency, and clinical outcomes of COVID-19
Jheng-Yan Wu, Wan-Hsuan Hsu, Ya-Wen Tsai, Ting-Hui Liu, Po-Yu Huang, Min-Hsiang Chuang, Szu-En Chin, Chih-Cheng Lai, Mei-Yuan Liu
Journal of Infection, doi:10.1016/j.jinf.2023.06.021
This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Declarations of interest All authors declared there was no conflict of interests Declaration of Competing Interest We have submitted our manuscript entitled, "The association between zinc deficiency, and clinical outcomes of COVID-19", to Journal of Infection for publication. We will not submit this paper to any another journal. All the authors have read the final version of the manuscript and have agreed to its content. All of the authors also declared that there was no conflict of interests.
References
Berger, Shenkin, Schweinlin, ESPEN micronutrient guideline, Clinical Nutrition
Chang, Liu, Wu, Lai, The association between corticosteroids and aspergillosis among COVID-19 patients, J Infect
Hsu, Shiau, Tsai, The effect of molnupiravir on post-acute outcome of COVID-19 survivors, J Infect
Jayawardena, Sooriyaarachchi, Chourdakis, Jeewandara, None
Jothimani, Kailasam, Danielraj, COVID-19: Poor outcomes in patients with zinc deficiency, Int J Infect Dis. Nov
Tabatabaeizadeh, Zinc supplementation and COVID-19 mortality: a metaanalysis, Eur J Med Res
Trinetx, None
Wu, Liu, Huang, Tsai, Lai, The effect of zinc on the outcome of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials, J Infect
Wu, Liu, Liu, Clinical efficacy of nirmatrelvir and ritonavir combination for treating diabetic patients with COVID-19, J Med Virol
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit